Specialist Nuclear Medicine Physician at Sefako Makgatho Health Sciences University (SMU) and Dr George Mukhari Academic Hospital (DGMAH), Dr Phumudzo Nemutaduni, has been awarded the Oncidium Foundation Award at the recently held Theranostics World Congress (TWC), in Cape Town. The accolade recognises her trailblazing work in advancing patient access to radioligand therapy, reinforcing the critical link between innovation and equity in cancer care.
The award was presented for her abstract, “Beyond the cure: Economic barriers threatening advanced radionuclide therapy,” which exposes systemic obstacles preventing many patients from benefiting from cutting-edge radiotheranostics. “Innovation in cancer care is only meaningful if patients can actually access it,” Dr Nemutaduni said. “This research is a call to action to bridge the gap between discovery and patient impact.”
As one of South Africa’s foremost nuclear physicians, Dr Nemutaduni has become a leading authority on prostate cancer imaging and therapy. She is also the founder of Precision Nuclear Oncology & Theragnostic (PNOAT), Nuclear Med Group, and Embrace Health Medical Centre in Rustenburg. These facilities deliver advanced imaging and therapy while serving as training hubs, strengthening the national capacity for nuclear medicine. “We aim not only to treat patients but to train the next generation, ensuring knowledge and innovation are shared,” Dr Nemutaduni explained.
Raised in Mauluma, Nzhelele, in Venda, she credits her upbringing for instilling resilience, discipline, and a profound sense of community service. Dr Nemutaduni holds a Fellowship in Positron Emission Tomography – Computed Tomography (PET/CT) Imaging from Universitas Hospital in Zurich, Switzerland and contributes to healthcare governance as a member of the South African Health Products Regulatory Authority (SAHPRA) Advisory Committee, overseeing the safe deployment of health technologies in South Africa.
Her approach to medicine reflects the principles of top communicators and leaders: clarity, urgency, and relevance. “Whether it’s research, clinical care, or advocacy, every word, every action must deliver impact,” she said. This philosophy is evident in her writing and presentations, which capture attention quickly and inspire action—qualities recognised globally.
Dr Nemutaduni’s recognition is more than a personal accolade—it celebrates vision, determination, and commitment to patient-centred care. By addressing inequities, mentoring emerging clinicians, and creating institutions that bridge research and care, she ensures innovation translates into tangible benefit. “I hope this award inspires others to pursue excellence with impact,” she said.
‘I would like to thank my research team — Girum Tesema, Xolile Msingaphantsi-Khuzwayo, Nkululeko Mlaba, Mamokete Nonyane and Andrew More — for their unwavering dedication to the patients at DGMAH. I also extend my sincere gratitude to my mentors and supervisors, Professor Mike Sathekge and Professor Nozipho Nyakale,’ said Dr Nemutaduni.
Her leadership exemplifies how excellence, when combined with social responsibility, can transform healthcare outcomes and inspire generations to follow.
By Tumelo Moila
